Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer | |
Chu, Xiao; Zhou, Qi; Xu, Yingchun; Jiang, Jingting; Li, Qing; Zhou, Qianjun; Wu, Qiong; Jin, Min; Wang, Hui; Gu, Yuting | |
刊名 | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
2019 | |
卷号 | 38 |
关键词 | Fatty acid receptor FFAR4 Hormone receptor-positive breast cancer Fatty acids Gas chromatography-mass spectrometry Tumor microenvironment Biomarker Endocrine resistance |
ISSN号 | 1756-9966 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3595628 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Chu, Xiao,Zhou, Qi,Xu, Yingchun,et al. Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer[J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,2019,38. |
APA | Chu, Xiao.,Zhou, Qi.,Xu, Yingchun.,Jiang, Jingting.,Li, Qing.,...&Zhang, Yanyun.(2019).Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer.JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,38. |
MLA | Chu, Xiao,et al."Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer".JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 38(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论